Navigation and service

focus

  1. Medicinal Products
  2. Federal Opium Agency
  3. Medical Devices
  4. Research
Medical Products

Medicinal Products

Medicinal products are substances that are used to treat diseases, to relieve complaints, or to prevent such diseases or complaints in the first place. More

Federal Opium Agency

Federal Opium Agency

The Bundesopiumstelle (Federal Opium Agency) is one of 13 departments at the Federal Institute for Drugs and Medical Devices. More

Medical Devices

Medical Devices

Medical devices are products that have a medical purpose and are intended by the manufacturer for use in humans. More

Research

Research

Research at the BfArM concentrates on important and contemporary research focal points with regard to the marketing authorisation of medicinal products and improving the safety thereof as well as concerning the recording and assessment of risks in connection with medical devices. More

Medicinal Products

(Medicinal products are substances that are used to treat diseases, to relieve complaints, or to prevent such diseases or complaints in the first place. More

  1. Risk information on
    medicinal products
  2. Risk information on
    medical devices

Risk information on
medicinal products

2018.07.06Information letter on Fiasp® (insulin aspart): New colour scheme for cartridges …

The company Novo Nordisk Pharma GmbH is circulating information on the fact that a new colour scheme will be introduced for Fiasp® products as of July 2018 in order to improve their …

2018.07.05Dear Doctor Letter (Rote-Hand-Brief) on finasteride: Risk of sexual dysfunction …

Marketing Authorization Holders are circulating information on the risk of developing sexual dysfunctions and psychiatric symptoms under treatment with finasteride.

2018.06.29Medicinal products containing hydroxyethyl starch (HES): PRAC confirms its …

The CMDh is introducing new measures in order to protect patients.

more

2018.06.25Dear Doctor Letter (Rote-Hand-Brief) on darunavir/cobicistat: Increased risk of …

The company Janssen-Cilag GmbH is circulating information on the fact that treatment with darunavir/cobicistat should not be initiated during pregnancy.

Overview

Risk information on
medical devices

2016.12.22Cleaning and disinfection of heater-cooler-units (HCUs): possible influence on …

Cleaning and Disinfection of heater-cooler-units (HCUs): possible influence on oxygenator integrity

more

2016.05.13Urogynecological use of surgical meshes

The BfArM would like to draw attention to the recent SCENIHR publication regarding the use of surgical meshes in urogynecological surgery.

more

2015.01.29Advices for the application of NaCl basin liners

Advices for the application of NaCl basin liners

more

2014.11.18Recommendations on the approach to patients with Riata and Riata ST leads (St.

The German Cardiac Society (DGK) has published recommendations regarding patients with silicone insulated defibrillation leads Riata and Riata ST of St. Jude Medical.

more

Overview

Additional Information

Reporting risks to the BfArM